KFSHRC Celebrates Milestone in Kidney Transplants
Saudi Arabia, July 2024: King Faisal Specialist Hospital and Research Centre (KFSHRC) has successfully performed 5,000 kidney transplants since the inception of... Read more.
Pregnancy and Seafood: Safe Amounts, Big Benefits? New Research Offers Answers
Boston- June 2024- Fish consumption during pregnancy is a complex scientific topic. On one hand, fish are rich in nutrients essential to brain development, including... Read more.
RAKEZ Receives Award for Workplace Safety
UAE- June 2024- Ras Al Khaimah Economic Zone (RAKEZ) received the prestigious Silver Award from The Royal Society for the Prevention of Accidents (RoSPA), a British... Read more.
BenevolentAI, AstraZeneca Collaboration Hits New Milestone
London- June 2024: BenevolentAI announces that AstraZeneca has added a novel target for systemic lupus erythematosus (SLE) to its discovery portfolio through its... Read more.
Bupa is now the official health partner for the All Blacks rugby team
June 2024- Bupa has announced a global partnership with the All Blacks, Teams in Black and is also now the international healthcare partner of the Black Ferns. All... Read more.
Summer Safety: Are You Prepared to Keep Your Kids Cool?
Doha, Qatar- June 2024- With schools closed and children at home for the long summer break, Hamad Medical Corporation (HMC) reminds parents and caregivers to protect... Read more.
Lilly and OpenAI Team Up Against Superbugs
June 2024- Eli Lilly and Company announced a collaboration with OpenAI that will allow Lilly to leverage OpenAI’s generative AI to invent novel antimicrobials... Read more.
Latest: AbbVie Acquires Celsius Therapeutics
North Chicago- June 27, 2024- AbbVie announced the acquisition of Celsius Therapeutics, Inc. (“Celsius”), a privately held biotechnology company pioneering... Read more.
Breakthrough! New Weapon Strikes Down Breast Cancer Recurrence
June 2024- A year of treatment with a medicine made of an antibody and chemotherapy drug has proven highly effective in preventing stage 1 HER2-positive breast cancer... Read more.
Danaher appoints Julie Sawyer Montgomery as Executive Vice President for Diagnostics
Washington- June 2024- Danaher Corporation announced that Julie Sawyer Montgomery will succeed Joakim Weidemanis as Executive Vice President, Diagnostics effective... Read more.
